I27.21 Billable / specific Secondary pulmonary arterial hypertension
ICD-10-CM I27.21 identifies “Secondary pulmonary arterial hypertension” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 9: Diseases of the circulatory system
Code-level instructions
Inclusion terms2
- (Associated) (drug-induced) (toxin-induced) pulmonary arterial hypertension NOS
- (Associated) (drug-induced) (toxin-induced) (secondary) group 1 pulmonary hypertension
Code also10
- associated conditions if applicable, or adverse effects of drugs or toxins, such as:
- adverse effect of appetite depressants (T50.5X5)
- congenital heart disease (Q20-Q28)
- human immunodeficiency virus [HIV] disease (B20)
- polymyositis (M33.2-)
- portal hypertension (K76.6)
- rheumatoid arthritis (M05.-)
- schistosomiasis (B65.-)
- Sjögren syndrome (M35.0-)
- systemic sclerosis (M34.-)
Inherited instructions
Chapters 9 · Diseases of the circulatory system (I00-I99)
Excludes 210
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
- systemic connective tissue disorders (M30-M36)
- transient cerebral ischemic attacks and related syndromes (G45.-)
I27.2 · Other secondary pulmonary hypertension
Excludes 11
Eisenmenger's syndrome (I27.83)
Code also1
associated underlying condition
Official index references
Official index references (3)
Hypertension, hypertensive(accelerated) (benign) (essential) (idiopathic) (malignant) (systemic) (3)
- Hypertension, hypertensive(accelerated) (benign) (essential) (idiopathic) (malignant) (systemic) › pulmonary › arterial(associated) (drug-induced) (toxin-induced)Disease index
- Hypertension, hypertensive(accelerated) (benign) (essential) (idiopathic) (malignant) (systemic) › pulmonary › group 1(associated) (drug-induced) (toxin-induced)Disease index
- Hypertension, hypertensive(accelerated) (benign) (essential) (idiopathic) (malignant) (systemic) › pulmonary › secondary › arterialDisease index
Official conversion history
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: I27.2
References from other codes (2)
Excludes 1 · secondary pulmonary arterial hypertension (I27.21)
Code also · secondary pulmonary arterial hypertension (I27.21)
History
Code history
Latest recorded change · FY2018
Effective from
- Added
Secondary pulmonary arterial hypertension
Billable diagnosis code
CDC/NCHS · FY2018All editions (17)
| All editions | Effective from | Code history |
|---|---|---|
| FY2018 | 2017-10-01 | Added |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 416.8 · Approximate
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.